Betamethasone Sodium Phosphate Solubility in PG Blends
Solubility Cliffs in Propylene Glycol-Water Blends: Mapping Critical Ratios for Betamethasone Sodium Phosphate
When formulating injectable or topical corticosteroid intermediates, R&D managers frequently encounter a sharp solubility cliff when blending propylene glycol (PG) with water for Betamethasone Sodium Phosphate (CAS 151-73-5). As a drop-in replacement for branded Celestone Phosphate, our Betamethasone 21-phosphate disodium salt exhibits identical performance benchmarks, but its solubility behavior in PG-water systems demands precise ratio control to avoid precipitation during scale-up.
In pure water, the solubility of this anti-inflammatory API exceeds 500 mg/mL at 25°C, driven by the dianionic phosphate group. However, as PG fraction increases, solubility declines non-linearly. At 40% v/v PG, solubility remains above 300 mg/mL, but at 60% PG, it drops to approximately 150 mg/mL. Beyond 70% PG, a metastable zone appears where supersaturated solutions can persist for hours before sudden crystallization. This is critical for formulators using PG as a co-solvent or penetration enhancer in topical emulsions. A related deep dive into rheology control in Betamethasone Sodium Phosphate topical emulsions can be found in our knowledge base.
Field experience reveals a non-standard parameter: at sub-zero temperatures (e.g., -5°C), the viscosity of 50% PG blends increases by a factor of 3, which slows nucleation kinetics but also reduces the maximum achievable concentration before gelation occurs. This is often overlooked in standard solubility tables.
| PG Concentration (% v/v) | Approximate Solubility at 25°C (mg/mL) | Observed Behavior |
|---|---|---|
| 0 | >500 | Clear, low viscosity |
| 40 | ~320 | Stable for 48 hours |
| 60 | ~150 | Metastable; risk of precipitation |
| 80 | <50 | Rapid crystallization |
For reliable formulation, we recommend staying below 50% PG unless a validated heating/cooling cycle is employed. Please refer to the batch-specific COA for exact solubility data, as trace impurities can shift the precipitation boundary.
Micro-Precipitation Dynamics: Impact of Trace Free Betamethasone and High-Shear Mixing on Filtration Blockages
During sterile filtration of Betamethasone Sodium Phosphate solutions, a common field issue is filter blockage caused by micro-precipitation of free betamethasone base. Even at USP Grade purity, trace levels of the neutral alcohol form (typically <0.1%) can nucleate in PG-rich environments. Under high-shear mixing, localized heating can temporarily increase solubility, but upon cooling, submicron particles form that pass initial clarity tests yet clog 0.22 µm sterilizing filters.
Our GMP Facility produces Betamethasone 21-Phosphate Disodium Salt with controlled free betamethasone levels, verified by HPLC. However, formulators should note that the solubility parameter of propylene glycol (δ ≈ 30.7 MPa^0.5) is closer to that of the free base than water, so PG can actually solubilize free betamethasone better than water. The problem arises when water is added to a PG concentrate: the free base precipitates first, acting as seeds for the disodium salt. A practical mitigation is to pre-dissolve the API in water, then add PG slowly under low-shear mixing. For freeze-dried injectables, understanding collapse prevention is equally critical; see our article on freeze-drying collapse prevention for Betamethasone Sodium Phosphate injectables.
pH-Dependent Solubility Curves and COA Parameters for Consistent Dosing in Multi-Ingredient Injectables
The solubility of Betamethasone Sodium Phosphate is highly pH-dependent due to the phosphate ester's pKa values (pKa1 ≈ 1.5, pKa2 ≈ 6.4). At pH below 4, the monoanionic species dominates, reducing solubility to less than 50 mg/mL. Above pH 7, the dianion ensures maximum solubility. However, in multi-ingredient injectables containing divalent cations (e.g., Ca²⁺, Mg²⁺), phosphate salt precipitation can occur even at neutral pH. Our COA includes a heavy metals limit of ≤20 ppm to minimize this risk.
For consistent dosing, always buffer the formulation to pH 7.0–7.5 using phosphate or citrate buffers. A non-standard observation: in PG-water blends, the apparent pH measured by a glass electrode can drift by +0.3 units due to solvent effects, leading to under-buffering. We recommend calibrating the pH meter in the same solvent background.
Bulk Packaging and Handling: IBC and 210L Drum Specifications for Betamethasone Sodium Phosphate Solutions
For global manufacturers scaling up production, we supply Betamethasone Sodium Phosphate as a white to off-white crystalline powder in 25 kg fiber drums, or as a concentrated aqueous solution in 210L HDPE drums or 1000L IBC totes. The solution form (typically 200 mg/mL in Water for Injection) is a drop-in equivalent to branded concentrates, offering significant bulk price advantages. Our logistics focus on physical packaging integrity: IBCs are nitrogen-blanketed to prevent oxidation, and 210L drums are fitted with tamper-evident seals. All shipments include a Certificate of Analysis (COA) and Safety Data Sheet (SDS).
When handling PG-blended solutions, note that the higher viscosity at low temperatures may require drum heaters for complete discharge. We do not claim EU REACH compliance; customers must verify regional regulatory requirements.
Frequently Asked Questions
What is the maximum propylene glycol concentration I can use without precipitation?
Based on our stability studies, up to 50% v/v PG is generally safe for concentrations up to 200 mg/mL Betamethasone Sodium Phosphate at 25°C. For higher PG levels, conduct a small-scale feasibility trial with your specific grade.
What filtration mesh size is recommended for sterile injectables?
Use a 0.22 µm PVDF or PES membrane filter. Pre-filtration through a 0.45 µm filter is advised if the solution shows any haze. Ensure the filter housing is compatible with PG.
How can I troubleshoot precipitation during formulation scaling?
First, check the pH and adjust to 7.0–7.5. If precipitation persists, reduce the PG fraction or add a small amount of polysorbate 80 (0.1% w/v) as a stabilizer. Verify the free betamethasone content in your API batch.
What is the solubility of betamethasone?
Betamethasone base is practically insoluble in water, but its sodium phosphate salt is freely soluble (>500 mg/mL). The solubility parameter of propylene glycol makes it a better solvent for the base, but the salt form prefers water-rich environments.
Does betamethasone have propylene glycol?
Commercial injectable formulations like Celestone Soluspan contain betamethasone sodium phosphate and betamethasone acetate in a vehicle with propylene glycol. Our Betamethasone 21-phosphate disodium is the same active ingredient used in such formulations.
What is the half-life of betamethasone sodium phosphate?
The plasma half-life of betamethasone sodium phosphate after intravenous administration is approximately 5–6 hours, but this is a pharmacokinetic parameter unrelated to solubility. For chemical stability in solution, the half-life at pH 7 and 25°C is several months.
Sourcing and Technical Support
As a leading global manufacturer of Betamethasone Sodium Phosphate, NINGBO INNO PHARMCHEM CO.,LTD. provides a reliable supply of this research chemical and pharmaceutical intermediate. Our product serves as a performance benchmark for anti-inflammatory API development. To request a batch-specific COA, SDS, or secure a bulk pricing quote, please contact our technical sales team.